. 2021 Feb 20;57:5–17. doi: 10.1016/j.breast.2021.02.009

Table 6.

Other recurrence outcomes in RCTs.

First Author (year) [trial name]	Intergroup Difference			Intervention		Comparator
First Author (year) [trial name]	Hazard Ratio	95% CI	p-value	Treatment	Proportion	Treatment	Proportion
TTR at 5 years

Ruiz-Borrego (2019) [GEICAM/2006–10]	NR	NR	0.406	Anastrozole	92.7%	Anastrozole + fulvestrant	94.0%
BCRR at 10 years
Knoop (2014) [DBCG 77C]	LA: 0.66	0.53–0.84	NR	Tamoxifen + radiotherapy	40.8%	Radiotherapy alone	55.1%
Knoop (2014) [DBCG 77C]	LB: 0.54	0.39–0.74	NR	Tamoxifen + radiotherapy	57.0%	Radiotherapy alone	69.1%

Abbreviations: BCRR = breast cancer recurrence rate; CI = confidence interval; LA = luminal A; LB = luminal B/HER2-; NR = not reported; RCT = randomized controlled trial.